Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Johnston

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Pharmacology|April 16, 2004
The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to dateThomas P Johnston
The Journal of Pharmacy and Pharmacology|December 5, 2009
Poloxamer 407 increases soluble adhesion molecules, ICAM-1, VCAM-1 and E-selectin, in C57BL/6 miceThomas P Johnston
Health Physics|January 1, 2015
ReactorHealth Physics operations at the NIST center for neutron researchThomas P Johnston
The Journal of Pharmacy and Pharmacology|November 9, 2010
Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 miceThomas P Johnston
Journal of Cardiovascular Pharmacology|April 18, 2007
Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effectThomas P Johnston, Xinghua Zhou
International Journal of Pharmaceutics|April 9, 2005
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epitheliumNazila Salamat-Miller, Thomas P Johnston
The Journal of Pharmacy and Pharmacology|July 29, 2006
Inhibition of pancreatic lipase by poloxamer 407 may provide an adjunct treatment strategy for weight lossThomas P Johnston, Ira J Goldberg
The Journal of Pharmacy and Pharmacology|May 24, 2008
The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalphaThomas P Johnston, David J Waxman
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Circulating free fatty acids are increased independently of PPARgamma activity after administration of poloxamer 407 to miceThomas P Johnston, David J Waxman
Current Pharmaceutical Design|May 24, 2018
One Molecule, Many Targets and Numerous Effects: The Pleiotropy of Curcumin Lies in its Chemical StructureMahdi Hatamipour, Thomas P Johnston, Amirhossein Sahebkar
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Pharmacology|April 16, 2004
The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to dateThomas P Johnston
The Journal of Pharmacy and Pharmacology|December 5, 2009
Poloxamer 407 increases soluble adhesion molecules, ICAM-1, VCAM-1 and E-selectin, in C57BL/6 miceThomas P Johnston
Health Physics|January 1, 2015
ReactorHealth Physics operations at the NIST center for neutron researchThomas P Johnston
The Journal of Pharmacy and Pharmacology|November 9, 2010
Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 miceThomas P Johnston
Journal of Cardiovascular Pharmacology|April 18, 2007
Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effectThomas P Johnston, Xinghua Zhou
International Journal of Pharmaceutics|April 9, 2005
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epitheliumNazila Salamat-Miller, Thomas P Johnston
The Journal of Pharmacy and Pharmacology|July 29, 2006
Inhibition of pancreatic lipase by poloxamer 407 may provide an adjunct treatment strategy for weight lossThomas P Johnston, Ira J Goldberg
The Journal of Pharmacy and Pharmacology|May 24, 2008
The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalphaThomas P Johnston, David J Waxman
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Circulating free fatty acids are increased independently of PPARgamma activity after administration of poloxamer 407 to miceThomas P Johnston, David J Waxman
Current Pharmaceutical Design|May 24, 2018
One Molecule, Many Targets and Numerous Effects: The Pleiotropy of Curcumin Lies in its Chemical StructureMahdi Hatamipour, Thomas P Johnston, Amirhossein Sahebkar
Pageof 16